GlassScriptPhysician profile
Amee Sodha
NPI 1548687569
$2,287.75
in general payments reported to CMS, 2019-2025
17 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $303 · 2021: $133 · 2022: $668 · 2023: $320 · 2024: $366 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $469.46 | 2022 | |
| Janssen Pharmaceuticals, INC | $329.87 | 2019-2024 | Xarelto |
| Monteris Medical Corporation | $261.86 | 2019 | |
| Pfizer INC. | $191.72 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $169.59 | 2019-2023 | Camzyos |
| Abbott Laboratories | $141.97 | 2024 | Amplatzer Amulet |
| Glaxosmithkline, LLC. | $124.28 | 2023 | |
| Amgen INC. | $102.50 | 2025 | Uplizna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.50 | 2022 | |
| Abbvie INC. | $87.52 | 2021-2024 | |
| Vivus LLC | $78.61 | 2024 | Qsymia |
| Merck Sharp & Dohme LLC | $60.62 | 2023 | Dificid, Zerbaxa, Recarbrio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.93 | 2024 | Lifevest |
| Allergan, INC. | $39.70 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $37.48 | 2020-2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Global Blood Therapeutics, INC. | $30.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $26.14 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amee Sodha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.